Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

BREAST CANCER

Interval breast cancers — insights into a complex phenotype

Interval invasive breast cancers diagnosed after a normal mammogram but before the next screening examination have a different tumour biology from that of screen-detected breast cancers, and thus are not detected on mammography. Understanding the genetics and biology of interval invasive cancers could inform better approaches to detection.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Houssami, N. & Hunter, K. The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening. NPJ Breast Cancer https://doi.org/10.1038/s41523-017-0014-x (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Henderson, L. M. et al. Breast cancer characteristics associated with digital versus film-screen mammography for screen-detected and interval cancers. Am. J. Roentgenol. 205, 676–684 (2015).

    Article  Google Scholar 

  3. Kerlikowske, K. et al. Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann. Intern. Med. 162, 673–681 (2015).

    Article  Google Scholar 

  4. Kirsh, V. A. et al. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program. J. Natl Cancer Inst. 103, 942–950 (2011).

    Article  Google Scholar 

  5. Drukker, C. A. et al. Mammographic screening detects low-risk tumor biology breast cancers. Breast Cancer Res. Treatment 144, 103–111 (2014).

    Article  CAS  Google Scholar 

  6. Mavaddat, N. et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am. J. Hum. Genet. 104, 21–34 (2019).

    Article  CAS  Google Scholar 

  7. Vachon, C. M. et al. The contributions of breast density and common genetic variation to breast cancer risk. J. Natl Cancer Institute 107, https://doi.org/10.1093/jnci/dju397 (2015).

  8. Li, J. et al. Differential burden of rare and common variants on tumor characteristics, survival, and mode of detection in breast cancer. Cancer Res. 78, 6329–6338 (2018).

    Article  CAS  Google Scholar 

  9. Grassmann, F. et al. Interval breast cancer is associated with other types of tumors. Nat. Commun. 10, 4648 (2019).

    Article  CAS  Google Scholar 

  10. Antoniou, A. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet. 72, 1117–1130 (2003).

    Article  CAS  Google Scholar 

  11. Goggins, W., Gao, W. & Tsao, H. Association between female breast cancer and cutaneous melanoma. Int. J. Cancer 111, 792–794 (2004).

    Article  CAS  Google Scholar 

  12. Klein, A. P. Genetic susceptibility to pancreatic cancer. Mol. Carcinog. 51, 14–24 (2012).

    Article  CAS  Google Scholar 

  13. Kerlikowske, K. et al. Strategies to identify women at high risk of advanced breast cancer during routine screening for discussion of supplemental imaging. JAMA Intern Med. 179 1230–1239 (2019).

    Article  Google Scholar 

  14. Zhang, H. et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. bioRxiv. https://doi.org/10.1101/778605 (2019).

    Article  Google Scholar 

  15. Bakker, M. F. et al. Supplemental MRI screening for women with extremely dense breast tissue. N. Engl. J. Med. 381, 2091–2102 (2019).

    Article  Google Scholar 

Download references

Acknowledgements

The authors received funding support from the National Cancer Institute (P01CA154292, K24CA169004 and K08CA237829).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karla Kerlikowske.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shieh, Y., Ziv, E. & Kerlikowske, K. Interval breast cancers — insights into a complex phenotype. Nat Rev Clin Oncol 17, 138–139 (2020). https://doi.org/10.1038/s41571-020-0327-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41571-020-0327-9

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer